News
FDA approves treatment for opioid-induced constipation
On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer…
FDA approves new drug for Gaucher disease
On August 19, the U.S. Food and Drug Administration (FDA) approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1…
FDA approves new device that may boost number of lung transplants
On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated…
FDA approves new type of drug for insomnia
On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved orexin receptor…
FDA approves treatment for opioid-induced constipation
On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with…
FDA approves new drug for Gaucher disease
On August 19, the U.S. Food and Drug Administration (FDA) approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the…
FDA approves new device that may boost number of lung transplants
On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for…
FDA approves new type of drug for insomnia
On August 13, the U.S. Food and Drug Administration (FDA) approved Belsomra (suvorexant) tablets for treating insomnia. Belsomra is the first approved…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.